Correlation Between AXWAY SOFTWARE and Brainstorm Cell

Can any of the company-specific risk be diversified away by investing in both AXWAY SOFTWARE and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AXWAY SOFTWARE and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AXWAY SOFTWARE EO and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on AXWAY SOFTWARE and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AXWAY SOFTWARE with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of AXWAY SOFTWARE and Brainstorm Cell.

Diversification Opportunities for AXWAY SOFTWARE and Brainstorm Cell

-0.7

Correlation Coefficient

AXWAY SOFTWARE  Brainstorm Cell

Excellent diversification

The 3 months correlation between AXWAY and Brainstorm is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding AXWAY SOFTWARE EO and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and AXWAY SOFTWARE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AXWAY SOFTWARE EO are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of AXWAY SOFTWARE i.e., AXWAY SOFTWARE and Brainstorm Cell go up and down completely randomly.

Pair Corralation between AXWAY SOFTWARE and Brainstorm Cell

If you would invest  269.00  in Brainstorm Cell Therapeutics on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Brainstorm Cell Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

AXWAY SOFTWARE EO  vs.  Brainstorm Cell Therapeutics

AXWAY SOFTWARE EO

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in AXWAY SOFTWARE EO are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, AXWAY SOFTWARE reported solid returns over the last few months and may actually be approaching a breakup point.

Brainstorm Cell Ther

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with AXWAY SOFTWARE and Brainstorm Cell

The main advantage of trading using opposite AXWAY SOFTWARE and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AXWAY SOFTWARE position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.

The idea behind AXWAY SOFTWARE EO and Brainstorm Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.